Gastro-oesophageal Reflux Disease Trial, Recruiting NCT06042127 Sponsor: Chinese University of Hong Kong Condition: Gastro-oesophageal Reflux Disease
Back to Gord

Gastro-oesophageal Reflux Disease Trial, Recruiting

NCT06042127
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 65 years old who have been diagnosed with symptomatic achalasia type I or II (a swallowing condition where the food pipe has difficulty moving food into the stomach)
  • People who are able to understand the study requirements, complete certain questionnaires about symptoms, and sign a consent form
  • People with achalasia type I, II, or III who have never had treatment for it before, or whose previous balloon stretching procedures did not work

Who may not be able to join:

  • People who are unable or unwilling to give their consent to participate
  • People who have previously had surgery on their food pipe or stomach
  • People who have already had certain achalasia procedures, including Heller myotomy or POEM (specific surgical or endoscopic treatments for achalasia)
  • People whose food pipe has become very curved or severely widened (greater than 6cm in the lower section)
  • People who have damage or scarring to the inner lining of the lower food pipe, such as ulcers or fibrotic scars
  • People with a large hiatal hernia (where part of the stomach pushes up through the diaphragm) above a certain size
  • People with serious heart or lung conditions that may make general anaesthesia unsafe, including those rated at a higher-risk anaesthesia category (confirm with trial site)
  • People with obesity, defined as a Body Mass Index (BMI) of 30 or above
  • People who are pregnant, planning to become pregnant, or currently breastfeeding
  • People with blood clotting problems that cannot be corrected, based on specific blood test results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hon Chi Yip, FRCSEd, Chinese University of Hong Kong

Phone: 35052627

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 December 2023
Est. completion
31 October 2025

Where this trial is recruiting

🇨🇳 China Hong Kong 🇮🇳 India 🇺🇸 United States

Primary endpoints

Post-procedure rate of gastroesophageal reflux

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov